Stocks in Play: Crescita Therapeutics Inc.
Wednesday, May 14, 202510:09 AM EST - Crescita Therapeutics Inc. : Today reported its financial results for the first quarter ended March 31, 2025. Revenue was $3,537, compared to $4,996, a decrease of $1,459. Gross profit was $1,747, compared to $2,411, a decrease of $664. Operating expenses were $2,809, compared to $3,142, a decrease of $333. Net loss was $(932), compared to $(626), an increase of $306. Crescita Therapeutics Inc. (T.CTX) shares were down $0.01 at 0.52.Stocks in Play: Crescita Therapeutics Inc., Thu, 15 May 2025 03:42:05 EST
Recent Posts
Romanian Inflation Ends Tumultuous Year in Politics Close to 10%
UK Boosts Support For Offshore Wind in Bumper Auction
Ireland Is Trying to Get Back on the Data Center Bandwagon
Notice Concerning Change of Representative Executive Officer
Polish Recycler Bets Millions on Europe’s Critical Metals Push
Blistering Metals Rally Sends Silver, Tin and Copper to Records
Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities
TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
